Eucomed looks at pharma model to raise device profile
This article was originally published in Clinica
The European medical device industry association, Eucomed, is looking at new ways of raising the profile of the medical devices industry. Its public policy programme group will meet on September 6 to consider whether a medical device equivalent to the pharmaceutical industry's G10 high level group on innovation and the provision of medicines should be set up.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.